Boston Therapeutics, Inc. (5)
Browse by Contract Category
Contracts
-
Certificate of Designation Series B Preferred Stock
(Filed With SEC on February 2, 2021)
-
Agreement and Plan of Merger, dated February 2, 2021, by and between Boston Therapeutics, Inc.., BTHE Acquisition Inc. and Nanomix, Inc
(Filed With SEC on February 2, 2021)
-
Form of Debt Settlement and Release Agreement
(Filed With SEC on February 2, 2021)
-
Unwind Agreement between Boston Therapeutics, Inc., Cure DM, Inc. and Cure DM Group Holdings, LLC signed August 6, 2019
(Filed With SEC on August 19, 2019)
-
Form of Exchange Agreement
(Filed With SEC on February 2, 2021)